ASCENSIA DIABETES CARE PRESENTS NEW RESEARCH SHOWING THAT PEOPLE USING THE CONTOUR® BLOOD GLUCOSE MONITORING SYSTEM AND APP EXPERIENCE FEWER OUT-OF-TARGET BLOOD GLUCOSE LEVELS
- Written by PR Newswire Asia - Metro Digital RSS
 |
BASEL, Switzerland, May 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributor of the Eversense® continuous glucose monitoring (CGM) system, announces a new study demonstrating that people who use the connected CONTOUR® BGM...